“…T − 553 A
c. T−834A4 | 2 | Caucasian | AT genotype could be risk factor for PDR during T2DM | [50] | IGF-1 | Insulin-like growth factor 1 | Stimulation of cell growth and proliferation, inhibition of apoptosis | (CA)n | 4 | 2 | Southern Indian | 18-repeat of (CA) increases risk of DR | [51] |
EPO | Erythropoietin | Control of erythropoiesis, stimulation of proliferation, migration and angiogenesis in hypoxic cells | rs1617640, rs507392, rs551238 | 7 | 1 and 2 | Multi-ethnic, European American, Australian | TTA allele associated with PDR in European American, meta-analysis hasn´t found significant association; GCC haplotype associated with DR in Australian | [15, 52, 53] |
RAGE | Advanced glycosylation end product-specific receptor | Activation of pro-inflammatory genes | rs1800624 (c. T-374A) | 6 | 2 | Indian, Chinese, African-Brazilian, Caucasian - Scandinavian | Inconsistent finding and weak association, may be interacting with glycosylated hemoglobin | [15, 54–56] |
rs1800625 (c. T-429C) | 6 | 2 | Caucasian, Indians, Danish | Inconsistent finding and weak association, functional studies show differences in polymorphic receptor activity | [55–60] |
rs2070600 (p. G82S) | 6 | 2 | Caucasian, Indian, Chinese, Malaysian | Associated with DR, no association in Malaysian | [15, 58, 61] |
ACE I | Angiotensin-I converting enzyme | Component of the renin-angiotensin system—activation of angiotensin II | rs4646994 (c. G2350A)-INS/DEL at intron 16 | 17 | 1 and 2 | Caucasian - Slovene, Danish; J... |
…”